UPOSBI
Live / Applied — Fifth extension granted (statement of use) (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 25 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97380250
- Mark type
- Stylized text
- Filed
- 25 Apr 2022
- Published for opposition
- 21 Mar 2023
- Attorney of record
- Makiko Coffland
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of bone disorders, skeletal disorders, muscular disorders, ocular disorders, and tumors
Owner
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
Prosecution history
- 15 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2026 — SOU EXTENSION 5 GRANTED
- 21 Aug 2025 — SOU EXTENSION 5 FILED
- 14 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2025 — SOU EXTENSION 4 GRANTED
- 12 Feb 2025 — SOU EXTENSION 4 FILED
- 12 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Aug 2024 — SOU EXTENSION 3 GRANTED
- 30 Aug 2024 — SOU EXTENSION 3 FILED
- 30 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Mar 2024 — SOU EXTENSION 2 GRANTED